The Merlin test (CP-GEP), a molecular diagnostic tool developed by SkylineDx, shows promising results in reducing the need for sentinel lymph node biopsy (SLNB) in early-stage melanoma patients, ...
Some results have been hidden because they may be inaccessible to you